"
Team:Arizona State/IS
From 2013.igem.org
(Difference between revisions)
| Line 14: | Line 14: | ||
<p> | <p> | ||
| - | In addition to curating public feedback on our initial design, we interviewed cancer researchers and physicians to determine the optimal strategy for vaccine chassis design and the most effective components of vaccination essential to an effective immune response | + | In addition to curating public feedback on our initial design, we interviewed cancer researchers and physicians to determine the optimal strategy for vaccine chassis design and the most effective components of vaccination essential to an effective immune response, including: |
</p> | </p> | ||
| + | <ul> | ||
| + | <li> | ||
| + | GM-CSF expresion and secretion. | ||
| + | </li> | ||
| + | <li> | ||
| + | Utilization of a lowly-immunogenic bacterial vaccine strain to minimize destruction of the chassis before vaccine delivery. | ||
| + | </li> | ||
| + | <li> | ||
| + | text | ||
| + | </li> | ||
| - | + | <p> | |
| + | We then met with these experts following our revised experimental design to confirm their feedback. | ||
| + | </p> | ||
</body> | </body> | ||
</html> | </html> | ||
Revision as of 23:52, 27 September 2013
In addition to curating public feedback on our initial design, we interviewed cancer researchers and physicians to determine the optimal strategy for vaccine chassis design and the most effective components of vaccination essential to an effective immune response, including:
- GM-CSF expresion and secretion.
- Utilization of a lowly-immunogenic bacterial vaccine strain to minimize destruction of the chassis before vaccine delivery.
- text
We then met with these experts following our revised experimental design to confirm their feedback.
